欢迎您！东篱公司
退出
-
申报数据库
-
立项数据库
-
成果数据库
-
项目获奖数据库
同期刊论文项目
同项目期刊论文
Immunohistochemical algorithm alone is not enough for predicting the outcome of patients with diffus
Know the enemy as well as the weapons in hand: the aberrant death pathways and therapeutic agents in
Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma tre
The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic l
Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and high
High level of CD20 expression by flow cytometry predicts good prognosis in chronic lymphocytic leuke
Polyclonal Antibody Targeting SOX11 Cannot Differentiate Mantle Cell Lymphoma From B-Cell Non-Hodgki
Expression levels of Lyn, Syk, PLC gamma 2 and ERK in patients with chronic lymphocytic leukemia, an
High expression of cyclic nucleotide phosphodiesterase 7B mRNA predicts poor prognosis in mantle cel
Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-
miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but n
Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the ag
MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B
位置：